Market Review: April 21, 2025

Closing Recap

Monday, April 21, 2025

Index

Up/Down

%

Last

DJ Industrials

-971.82

2.48%

38,170

S&P 500

-124.50

2.36%

5,158

Nasdaq

-415.55

2.55%

15,870

Russell 2000

-40.30

2.14%

1,840

 

 

 

 

 

 

 

 

 

U.S. stocks bled lower most of the trading day, with no notable bounces until the final 60 minutes, paring losses but still ended down sharply as investors remain leery about tariffs, trade deals, the economy, and the Fed, as President Trump renewed his attacks against Federal Reserve Chair Jerome Powell. Sentiment remains bleak as evident by recent AAII weekly polls and NAAIM data with lots of confusion in markets ahead of a busy earnings week (nearly 120 S&P 500 companies report this week including TSLA and GOOGL). Investors are concerned about company guidance given the trade barriers and tariff impacts that are difficult to quantify at this time. Stocks continue to bleed lower, bond markets are falling as yields rise (ending near the high), while the US dollar is getting crushed, which means the cost of imported goods is going higher on top of whatever the tariffs will apply. A tough situation for the White House, while the Fed seems content on seeing how things play out vs cutting rates or easing. So far, there have been trade talks with a few countries the last few weeks, including Japan late last week, but the lack of publicly announced deal progress is depressing the U.S. dollar, spiking bond yields and leading to a flight to safety to gold (making all-time highs above $3,400 today) and now Bitcoin with its move today.

 

White House economic adviser Kevin Hassett said on Friday that Trump and his team would study whether firing Fed chairman Powell was an option, a day after Trump’s comments that Powell’s “termination cannot come fast enough”. That was followed up by harsher words this morning from Trump saying on Truth Social; “Preemptive Cuts” in Interest Rates are being called for by many. With Energy Costs way down, food prices (including Biden’s egg disaster!) substantially lower, and most other “things” trending down, there is virtually No Inflation. With these costs trending so nicely downward, just what I predicted they would do, there can almost be no inflation, but there can be a SLOWING of the economy unless Mr. Too Late, a major loser, lowers interest rates, NOW. Europe has already “lowered” seven times. Powell has always been “To Late,” except when it came to the Election period when he lowered in order to help Sleepy Joe Biden, later Kamala, get elected. How did that work out?”

 

Commodities, Currencies & Treasuries

  • June gold prices rose $96.90 to $3,425.30 an ounce (hit highs of $3,442.30 earlier). Gold prices hit a record high as a faltering dollar and worries about a global economic slowdown over rising U.S.-China trade tensions kept safe-haven bullion in demand. U.S. President Donald Trump’s broad tariffs and the uncertainty surrounding his trade policies have impacted global markets and clouded the economic outlook.
  • WTI crude oil prices retreated, falling -$1.60 or 2.47% to settle at $63.08 per barrel as traders remain concerned over the impact of the US-led trade war on energy demand, while signs of progress in talks between Washington and Tehran eased concerns about supplies from Iran. U.S. natural gas futures continue losses, prices down by 5% to 11-week low on record output, forecasts for mild weather and low demand.
  • The US dollar hit over a three-year low, making greenback-priced bullion cheaper for overseas buyers. Meanwhile, China warned countries against striking a broader economic deal with the U.S. at its expense. Longer-dated U.S. Treasury yields rose as investors watched the escalating Trump administration attacks on Fed Chair Powell. The yield on the benchmark U.S. 10-year Treasury note was up about 8pbs late day at highs above 4.41%.

 

Macro

Up/Down

Last

WTI Crude

-1.60

63.08

Brent

-1.70

66.26

Gold

96.90

3,425.30

EUR/USD

0.0122

1.1513

JPY/USD

-1.46

140.71

10-Year Note

0.084

4.411%

 

Sector News Breakdown

Autos, Retail, Consumer Staples & Restaurants:

  • In Autos: TSLA shares fell again ahead of earnings this week; Wedbush analyst Dan Ives said Elon Musk should step back from his controversial work at the Department of Government Efficiency and re-focus his attention on Tesla Inc., adding the electric-vehicle maker faces a “code red” moment as it prepares to report first-quarter earnings. Separately, TSLA’s production launch for an affordable car has been delayed, Reuters reports, citing three sources. Global production of the lower-cost Model Y is expected to begin in the U.S. UBER shares slide after U.S. FTC filed a lawsuit against Uber accusing it of deceptive practices related to its Uber One subscription service.
  • In Retailers: AMZN downgraded to Outperform from Strong Buy at Raymond James (tgt cut to $195 from $275) saying the Street is underestimating EBIT pressures in 2025-26. Reports indicated President Trump to meet with WMT, TGT, HD and LOW executives as tariff angst spreads.

Energy, Industrials and Materials

  • In Oil & Gas: Keybanc downgraded MUR to Sector Weight from Overweight and upgraded EXE to Overweight ($130 PT) as in Oil & Gas while lower price tgts across the board in sector. Keybanc said mark to market Q125 estimates ahead of the earnings season, lower its oil price forecast, and raise its natural gas price forecast. The firm said they believe oil prices are overly pressured near term, pricing in worst case outlooks on OPEC+ growth, U.S. oil growth, and a global recession, and it remains above the current NYMEX WTI futures strip. CVX has started oil and natural gas production in the Ballymore prospect of the Gulf of America; said Ballymore is the latest in a series of projects aimed at getting its Gulf oil production up to 300,000 net barrels per day in 2026.
  • In Chemicals: LYB and DOW both added as catalyst call Buys into earnings at Deutsche Bank saying the upcoming Q1 earnings release will be a clearing event and catalyst for the shares. Scotia said that CF is a relative winner in fertilizer sector after last week, the U.S. Administration announced its intention to proceed with fees for Chinese built ships that dock at U.S. ports. Over time, total levies could be as much as $1.5M per ship, depending on a detailed fee table.
  • Utility (CEG, OKLO, VST) and Data center (VRT, DELL, SMCI) related names tumbled today after Wells Fargo noted according to their industry sources, AMZN AWS has paused a portion of its leasing discussions on the colocation side. The firm said its not clear as to the magnitude of the pause, but says positioning is similar to what they heard from $MSFT and are digesting aggressive recent lease up deals. Meanwhile, TD Cowen noted their checks indicate ~1.9GW of 1Q25 hyperscale leasing led by ORCL and AMZN, followed by CRWV and GOOG, although industry sentiment around hyperscale demand has moderated as AMZN pulls back slightly (tied to U.S. colo deals). 1Q25 enterprise leasing was strong, up both Q/Q and Y/Y. Importantly, our checks indicate material MSFT equipment order cancellations for long-lead time DC equipment.
  • In Metals & Mining: Gold and silver miners seeing the biggest gains as RGLD, AEM, EGO, FNV, KGC, SAND, WPM among precious metal miners hitting 52-week highs as gold surged more than 3%.
  • In Aerospace & Defense: sector in focus with earnings tomorrow from LMT, NOC, RTX.

Banks, Brokers, Asset Managers:

  • In Banks: CMA Q1 EPS $1.25 with net interest income $575M vs. est. $563M; NIM 3.18% vs. est. 3.15% and Provision for credit losses $20M, vs. est. $22.9M. Jefferies downgraded Canadian Banks CM and NTIOF to Hold from Buy as anticipate credit weakness to be more pronounced on the personal side, commercial lending is anticipated to weaken as well. SFNC upgraded to Neutral from Underweight at Piper after a bumpy credit qtr took the shares down over 3%, the firm said. INDB Q1 adj EPS $1.06 vs est. $1.16 on NII $145.505Mm vs est. $144.97, NIM 3.42%; raised quarterly dividend by 4% in Q1.

Insurance, Bitcoin, FinTech, Payments:

  • In Consumer Finance: COF received approval from US regulators to buy DFS, in a deal that creates the nation’s biggest credit-card issuer by loan volume.
  • In Payments: GPN was downgraded to Hold from Buy at TD Cowen and FIS upgraded to Buy from Hold after the company entered into a definitive agreement to acquire GPN’s Issuer Solutions business for an enterprise value of $13.5B. FIS has entered into an agreement to sell its stake in Worldpay to Global Payments for $6.6B in pre-tax value. GPN downgraded to Hold at Jefferies after Worldpay acquisition and cut its tgt to $75 from $100 saying it is clear that scale-driven deals in merchant acquiring are unlikely to work, says the firm
  • In Crypto: Bitcoin prices rose; MSTR said it sold 1.755M shares for $547.7M from April 14-20 as per SEC filing and acquires 6,556 Bitcoin for $555.8M; Bitcoin prices outperformed despite weaker stock markets all day, rising over 3.8% above $88,300 and boosting crypto miner stocks.

Biotech & Pharma:

  • Biotech (XBI, IBB) got a bounce this morning as analysts cited comments by new FDA Commissioner Dr. Marty Makary who was interviewed by Megyn Kelly over an hour-long session that provided the most comprehensive overview of his vision for the FDA under his leadership since he assumed the role according to RBC Capital. Most importantly for biopharma, RBC believes he came across as scientifically grounded level-headed with regards to registrational requirements (slimmed down animal testing), drug approval processes (aim to expedite on pathway plausibility, particularly for orphan diseases), and modernizing data capture, and willing to work with industry appropriately.
  • Hospital operators (UHS, HCA, THC) were broadly weaker; the WSJ this weekend noted Hospital Chains’ Medicaid profits are a juicy target for GOP budget hawks; article noted Republicans looking for cost savings could sink profits at Universal Health Services, others.
  • IMVT announced its next phase of growth with ROIV including changes to its leadership team and additional indications Sjögren’s Disease and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
  • NTLA upgraded to Outperform from Peer Perform at Wolfe Research with a $21 price target
  • PCRX authorizes a $300M share repurchase program.
  • REGN and SNY said the U.S. FDA has approved Dupixent for the treatment of adults and adolescents aged 12 years and older with chronic spontaneous urticaria who remain symptomatic despite histamine-1 antihistamine treatment.
  • TEM was initiated with a Buy at BTIG with price tgt $60 saying Tempus AI is a rapidly growing precision medicine platform technology company, which has "done a good job in its early days" to monetize its genomics and data business to medical oncologists and with pharma companies.

Internet, Media & Telecom

  • In Media Movers: NFLX shares rally on better results and guidance for Q2 (sees Q2 revs $11.04B vs est. $10.902B and EPS $7.03 vs est. $6.28) with no change to FY guide for revs, operating margin; DIS was upgraded to Outperform from Peer Perform at Wolfe Research with $112 tgt; WMG was downgraded to Equal Weight at Morgan Stanley as it lowers estimates to reflect more conservative industry and company growth expectations; it is roughly 2-4% below consensus.
  • In Semiconductors: NVDA shares declined after Reuters reported Huawei Technologies plans to begin mass shipments of its advanced 910C artificial intelligence chip to Chinese customers as early as next month, two people familiar with the matter said; some shipments have already been made, they added. In Semi-equipment: AMKR was downgraded to Neutral at B Riley and they cut ACLS to Neutral from Buy (tgt to $50 from $80) ahead of earnings as expects in-line Q125 results and Q225 guidance aided by Q424’s $645M backlog. Yet, on now-elevated capacity spending risk, cut 2H25 and 2026 ests and fear China tariff COGS risk.
  • In Software: CRM was upgraded to Neutral from Sell at Guggenheim this morning while DA Davidson downgraded to Underperform from Neutral (PT cut to $200 from $250).

_________________________________________________________________

Market commentary provided by Hammerstone Markets, Inc, a firm separate from and not affiliated with Regal Securities. Regal Securities has not participated in the creation of the content, and does not explicitly or implicitly endorse the content.